Colorectal Cancer Trial, Recruiting NCT02292641 Sponsor: Imperial College London Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT02292641
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had colorectal cancer (a cancer of the large bowel or rectum) confirmed by a biopsy taken during normal medical care
  • People who have been diagnosed with colorectal cancer that has come back in the pelvic area (the lower part of the abdomen)
  • People who have already had surgery to remove a primary cancer of the colon, sigmoid colon (the lower part of the large bowel), or rectum
  • People who are able to have a high-detail MRI scan to help plan treatment
  • People who have given written consent to take part in the study
  • People aged 16 years or older

Who may not be able to join:

  • People whose cancer has spread outside the pelvis to areas that cannot be removed by surgery
  • People for whom the original staging scans (MRI or CT scans taken before and after initial treatment) are no longer available
  • People whose records of their original surgery, pre-surgery treatment, or any additional treatment after surgery are incomplete or unavailable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gina Dr Brown, MD, Imperial College London

Phone: +44 (0) 7749 655 817

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 September 2014
Est. completion
1 December 2026

Where this trial is recruiting

🇳🇴 Norway 🇬🇧 United Kingdom

Primary endpoints

To change R0 resection rates for locally recurrent rectal cancers with the use of the proposed staging system.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov